Skip to content

Clinical trials

Phase 3 Mood Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Phase: Phase 3 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20085
20113
20122
20141
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Takeda4
Eli Lilly and Company2
GlaxoSmithKline1
Good Samaritan Regional Medical Center, Oregon1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
University of Cincinnati1
VA Office of Research and Development1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders16
Depressive Disorder9
Major Depressive Disorder9
Mental Disorders5
Anxiety Disorders3
Generalized Anxiety Disorder3
Affective Disorders, Psychotic1
Bipolar Disorder1
Chronic Pain1
Dysthymic Disorder1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.